Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index (AMEX:RSY)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index Charts. Click Here for more Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index Charts.](/p.php?pid=staticchart&s=A%5ERSY&p=8&t=15)
Recom Managed Systems (AMEX:RSY) announced today that it
has added two members to its board of directors. Business leader
Rowland Perkins, co-founder of one of the top talent and literary
agencies in Los Angeles, will serve as a member of the board's
compensation committee. Also named to the board was Norma Provencio,
who will serve as an independent member of the board's audit
committee.
Mr. Perkins, who co-founded Creative Artists Agency and served as
its president, joined the board effective immediately. Creative
Artists Agency, which was co-founded by Hollywood moguls such as
Michael Ovitz and Ron Meyer, has acted as one of the most powerful
business organizations in the country. It was co-founded by Mr.
Perkins in 1975 following his very successful 16-year career with
stalwart William Morris Agency. There, Mr. Perkins ultimately
supervised the television development division, where he helped
introduce the concept of "motion pictures for television" and presided
over the development of dozens of television projects, many of which
reached the fall schedule. Creative Artists Agency ultimately assisted
many national and international companies in broad marketing and
business-consulting efforts.
Mr. Perkins, who has replaced Lucy Duncan-Scheman, will assist new
company chair, Chief Executive Officer Pamela Bunes, in media
evaluation and exposure during Recom's critical and ongoing
"go-to-market" transition. Ms. Bunes was unanimously voted by the
board to serve as its chair now that the company's managerial
operations have successfully moved to Greenville, S.C. The company
maintains its office, information systems and technical laboratories
in Los Angeles.
Commenting on the addition of Mr. Perkins, Ms. Bunes said, "We are
very gratified that a person of Mr. Perkins' caliber will be available
as a board member for consultation and assistance. His experience for
two decades at Creative Artists Agency alone -- where that company
became a prominent leader in many diversified business services
encompassing advertising (Coca-Cola), investment and banking
advisement (Sony/Columbia) and other consultation for companies in
communications and technology fields -- is experience that represents
a perfect fit for us at this juncture in the company's development."
Mr. Perkins has also been a longtime member of the Academy of
Television Arts and Sciences and has served on its board of governors.
He also has been a longtime member of the Hollywood Radio and
Television Society and served on its board of directors. Mr. Perkins
has been active in consulting and board-membership roles for several
successful companies over the past decades.
Also added to the audit committee of Recom's board of directors
was independent board member Norma Provencio. Ms. Provencio has a
25-year career where she was partner of international accounting
firms, the last one being KPMG. Ms. Provencio currently serves as a
consultant to health care companies and is active philanthropically
through various foundations.
Dr. Lowell Harmison, one of Recom's long-term board members for
more than two years, commented, "We are very happy to welcome Mr.
Perkins and Ms. Provencio. I have personally been very satisfied with
how smoothly and quickly the company has developed its East Coast
presence through, among other things, the opening of the South
Carolina office. As the company now looks to access media and
associated commercialization with more focus, the addition of Mr.
Perkins is exciting and timely. Continuing to bring on experienced and
independent board members -- and financial experts such as Ms.
Provencio -- is also salutary and critical to the appropriate
constituency of the company's board for purposes of its new national
listing on the American Stock Exchange and its continued governance
going forward."
About Recom Managed Systems, Inc.
Recom Managed Systems, Inc. is an emerging life-sciences company
focused on the monitoring and detection of disease through continuous
biomedical signal monitoring. Recom Managed Systems, Inc. uses its
patented signal technology to design and develop medical devices that
simplify and reduce the costs of diagnostic testing and patient
monitoring in an ambulatory setting. With its patented
signal-technology platform, Recom brings clinical-quality
physiological signal monitoring to the ambulatory setting.
Recom's first product, the Model 100 Heart Monitor, is an
ambulatory patient heart monitor that uses patented signal-processing
technology to record a clinical-quality ECG signal in the presence of
interference generated by the patient's body movements and ambient
environment. The Model 100 has received 510(k) clearance from the Food
and Drug Administration.
Recom Managed Systems, Inc. is traded on the American Stock
Exchange under the symbol RSY. More information is located at
http://www.recom-systems.com.
Caution Regarding Forward-Looking Statements
Statements in this release that are not strictly historical are
"forward-looking" statements. Forward-looking statements involve known
and unknown risks, which may cause Recom's actual results in the
future to differ materially from expected results. Factors which could
cause or contribute to such differences include, but are not limited
to, failure to complete the development and introduction of new
products or services, failure to obtain federal or state regulatory
approvals governing medical devices, monitoring and other related
services or products, inability to obtain physician, patient or
insurance acceptance of Recom's products or services, adverse
equity-market conditions and declines in the value of Recom's common
stock, and the unavailability of financing to complete management's
plans and objectives. These risks are qualified in their entirety by
cautionary language and risk factors set forth and to be further
described in Recom's filings with the Securities and Exchange
Commission.